Evidence map›Paper›PMID 34332602›Full record

ArticleCell communication and signaling : CCS2021

ecRESCUE: a novel ecDHFR-regulated RESCUE system with reduced RNA off-targeting activity.

Yihan Wang, Guo Li, Xiangyang Li, Yuzhe Wang, Xingxu Huang, Xiaoxiang Hu, Jianen Gao

Abstract read
In one paragraph

Article in Cell communication and signaling : CCS, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yihan Wang *National Research Institute for Family Planning, Beijing, 100081, China.
Guo Li *State Key Laboratory of Agrobiotechnology, China Agricultural University, Beijing, 100193, China.
Xiangyang LiSchool of Life Science and Technology, Shanghai Tech University, Shanghai, 200031, China.
Yuzhe WangState Key Laboratory of Agrobiotechnology, China Agricultural University, Beijing, 100193, China.
Xingxu HuangSchool of Life Science and Technology, Shanghai Tech University, Shanghai, 200031, China.
Xiaoxiang HuState Key Laboratory of Agrobiotechnology, China Agricultural University, Beijing, 100193, China. huxx@cau.edu.cn.
Jianen GaoNational Research Institute for Family Planning, Beijing, 100081, China. gaojianen@nrifp.org.cn.ORCID 0000-0001-7808-3254

Funding

National Genetically Modified Organisms Breeding Major Projects of China 2016ZX08009003-006National Key Research and Development Program of China 2016YFC1000307
6 · The paper itself

Abstract

The currently available RESCUE RNA base editing system demonstrates considerable potential for the treatment of genetic diseases at the transcriptional level. However, the relatively high incidence of off-target events hampers the precise RNA editing, thereby limiting its use in the clinical setting. This study describes a new RNA base editing method, named ecRESCUE, which utilizes inducible stabilization of the protein ecDHFR DD fused at the C-terminal of the original RESCUE system. In vitro experiments in 293T cells showed that the ecRESCUE editor markedly reduced the incidence of off-target single nucleotide polymorphisms without affecting the RNA A-to-I and C-to-U base editing efficiency. Altogether, these results demonstrate that the inducible ecRESCUE system represents an attractive approach to regulate and improve the outcome of the available RNA base editor with reduced off-targeting activity. Video Abstract.

Indexed as

CRISPR-Cas SystemsGenetic Diseases, InbornHEK293 CellsHumansMutationRNARNA EditingRNADihydrofolate reductase destabilization domainecRESCUEOff-targeting activityRESCUE systemRNA base editing

Identifiers

PMID34332602
PMCPMC8325194

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.